Recent research explored whether there is a relationship between proton pump inhibitor (PPI) use in irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO).
What role does the immune system play in endometriosis? Women's health expert, Leah Hechtman joins us to share her clinical wisdom on this topic.
It is estimated that the global prevalence of IBS is 11%. The most common cause of IBS is small intestinal bacterial overgrowth (SIBO) — in fact, a whopping 60-80% of IBS is due to this common condition, totalling a possible 500 million people worldwide.
Dr Steven Sandberg-Lewis is a leading pioneer in the field of SIBO and other functional gastrointestinal disorders. Today he shares his insights on the IBS - SIBO connection.
With the growing focus on the human microbiome there has been a profound shift in our understanding of the role of the gut in health and disease.
Probiotics have a plethora of applications. In this podcast we explore some medically diagnosed conditions for which they are clinically appropriate.